EBITDA: Income before interest, taxes, depreciation and amortization.
Boundless Bio, Inc. (BOLD) had EBITDA of $-6.10M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-5.36M |
|
-- |
|
-- |
|
$6.20M |
|
$-6.20M |
|
$0.84M |
|
$-5.36M |
|
$-5.36M |
|
$-5.36M |
|
$-5.36M |
|
$-5.36M |
|
$-5.36M |
|
$-6.20M |
|
|
EBITDA |
$-6.10M |
22.86M |
|
22.86M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$63.59M |
|
-- |
|
-- |
|
$63.59M |
|
$1.87M |
|
-- |
|
-- |
|
$1.87M |
|
$61.72M |
|
$61.72M |
|
$61.72M |
|
23.11M |
|
| Cash Flow Statement Financials | |
$-46.83M |
|
$62.42M |
|
$0.89M |
|
$18.43M |
|
$34.91M |
|
$16.48M |
|
$4.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.69% |
|
-8.69% |
|
-8.43% |
|
-8.69% |
|
$2.67 |
|
$-2.04 |
|
$-2.05 |
|